Exero Medical

Exero Medical develops a biodegradable wireless sensor for early detection of anastomotic leaks following GI surgery.

Health Tech & Life Sciences
Active
Seed Or Yehuda, Israel Founded 2018
Last updated 2026-07-20
Total raised
—
Last: Undisclosed Round 2025-02
Stage
Seed
Founded
2018
Headcount
13
HQ
Or Yehuda, Israel
Sector
Health Tech & Life Sciences

About

Exero Medical is a medical technology company developing monitoring solutions for post-operative care. Their mission is to empower healthcare providers with high-quality, actionable post-operative tissue healing data that can save lives, improve prognosis, and reduce the cost of care. The company's flagship product, xBar, is an FDA Breakthrough Designated system intended for the early detection of anastomotic leaks following gastrointestinal (GI) surgeries. Exero Medical was founded in 2018 by MEDX Xelerator, an Israeli Innovation Authority incubator, and Clalit HMO, the largest HMO in Israel.

Offices

Or Yehuda, Israel · HQ / main office

Q&A

What is Exero Medical's primary focus?
Exero Medical develops a biodegradable wireless sensor for the early detection of anastomotic leaks following GI surgery, aiming to prevent complications through early intervention.
When was Exero Medical founded?
Exero Medical was founded in September 2018.
How many employees does Exero Medical have?
Exero Medical has an employee count in the 11-50 range.
What was Exero Medical's most recent funding round?
In February 2025, Exero Medical raised $12,700,000. The lead investors were Tech Council Ventures and Longevity Venture Partners
What is Exero Medical's total funding to date?
Exero Medical has raised a total of $16,100,000 USD across all funding rounds.
What is the current product stage of Exero Medical's technology?
Exero Medical's product is currently in the clinical trial stage.
Which investors participated in Exero Medical's November 2018 funding round?
In November 2018, investors included Israel Innovation Authority.
Has Exero Medical received any special designations for its device?
In December 2020, the FDA granted breakthrough device designation for Exero Medical's wireless system for early detection of anastomotic leaks.

Team · 13

Erez Shor
Founder · CEO, Board Member
Matan Ben-David
Founder · Medical Director, Founder, Board Member
Amir Kraitzer
Founder · Founder, Observer
Ilana Fishman
VP Regulatory and Clinical Operations
Gilad Lerman
VP R&D
Noam Taichler
CFO
Eileen Ke
VP Business Development
Shai Policker
Chairman
Raissa Hacohen
Board Member
Mark Kolb
Observer
Prof. Nir Wasserberg
Scientific Advisor
Prof. Charles Knowles
Scientific Advisor
Deborah Nagle
Scientific Advisor

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical MonitorsDigital HealthcarePatient Remote Monitoring
Technologies
SensingMaterials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

medical-technologiessurgeryalert-systembiodegradablehospitalsmedical-devicessensorspatent-pendingleak-detectionmedical-devicesremote-sensingmonitoringsurgeonsremote-monitoringgastroenterologydigital-healthcare
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteexeromedical.com
LinkedInlinkedin.com/company/18838545

Identifiers & details

Founded2018-9
Employees (exact)13

Radar intelligence

Patents

EPO3

Web history (Wayback)

Domainexeromedical.com

Certificate / subdomain footprint

Subdomains10

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515919496
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2018-10-31
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events2 — shares_capital (1), annual_report (1)
Registered addressשרון אריאל 8 אור יהודה

Recent registry events

DateEvent
2025-11-23העברת מניות
2026-06-07דו~ח שנתי